Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
Publisher: Karger
E-ISSN: 2296-5262|40|1-2|7-13
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.40, Iss.1-2, 2017-01, pp. : 7-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract